Topographical distributions of allelic loss in individual non-small-cell lung cancers

American Journal of Pathology

Volumn 157, Issue 3, 2000, Pages 985-993

  Yatabe, Yasushi ^a   Konishi, Hiroyuki ^a   Mitsudomi, Tetsuya ^a   Nakamura, Shigeo ^b   Takahashi, Takashi ^b  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b Aichi Cancer Research Institute ^*

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ALLELE; ARTICLE; CARCINOGENESIS; CHROMOSOME 17P; CHROMOSOME 3P; CONTROLLED STUDY; DNA METHYLATION; GENE MUTATION; GENETIC ANALYSIS; GENETIC HETEROGENEITY; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LUNG CANCER; LUNG NON SMALL CELL CANCER; PATHOGENESIS; PRIORITY JOURNAL; TOPOGRAPHY;

EID: 0034494225     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64611-1     Document Type: Article

References (32)

1. Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking
2. A genetic model for colorectal tumorigenesis
3. Precursors to pulmonary neoplasia
4. Morphometric study of adenocarcinomas and hyperplastic epithelial lesions in the peripheral lung
5. Glandular neoplasia of the lung. A proposed analogy to colonic tumors
6. Bronchioloalveolar cell adenomas
7. Clonal growth of atypical adenomatous hyperplasia of the lung: Cytofluorometric analysis of nuclear DNA content
8. Molecular biology overview
9. Allelotyping demonstrates common and distinct patterns of chromosomal loss in human lung cancer types
10. Allelotype of non-small cell lung carcinoma - Comparison between loss of heterozygosity in squamous cell carcinoma and adenocarcinoma
11. Fractional allele loss data indicate distinct genetic populations in the development of non-small-cell lung cancer
12. Frequent allelic losses on chromosomes 2q, 18q, and 22q in advanced non-small cell lung carcinoma
13. Comparative allelotype of early and advanced stage non-small cell lung carcinomas
14. Prognostic significance of abnormal p53 accumulation in primary, resected non-small-cell lung cancers
15. Prognostic significance of p53 mutations and 3p deletions in primary resected non-small cell lung cancer
16. Patterns of p53 mutations in squamous cell carcinoma of the lung: Acquisition at a relatively early age
17. c-k-ras and p53 mutations occur very early in adenocarcinoma of the lung
18. Clonal evolution of lung tumors
19. Clonal genetic alterations in the lungs of current and former smokers
20. Molecular damage in the bronchial epithelium of current and former smokers
21. Multiple clonal abnormalities in the bronchial epithelium of patients with lung cancer
22. Three distinct regions involved in 3p deletion in human lung cancer
23. p53: A frequent target for genetic abnormalities in lung cancer
24. Detailed deletion mapping suggests the involvement of a tumor suppressor gene at 17p13.3, distal to p53, in the pathogenesis of lung cancers
25. Allele-specific loss in chromosome 9p loci in preneoplastic lesions accompanying non-small-cell lung cancers
26. Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma
27. Chromosomal duplication accompanies allelic loss in non-small cell lung carcinoma
28. Comparative genomic hybridization analysis detects frequent, often high-level, overrepresentation of DNA sequences at 3q, 5p, 7p, and 8q in human non-small cell lung carcinomas
29. Detection of c-ki-ras gene mutation in paraffin sections of adenocarcinoma and atypical bronchi-oloalveolar cell hyperplasia of human lung
30. Microallelotyping defines the sequence and tempo of allelic losses at tumour suppressor gene loci during colorectal cancer progression
31. MAD-related genes on 18q21.1, Smad2, and Smad4, are altered infrequently in esophageal squamous cell carcinoma
32. Mapping of a new target region of allelic loss to a 2-cM interval at 22q13.1 in primary breast cancer